Optimization of heavy chain and light chain signal peptides for high level expression of therapeutic antibodies in CHO cells.
Translocation of a nascent protein from the cytosol into the ER mediated by its signal peptide is a critical step in protein secretion. The aim of this work was to develop a platform technology to optimize the signal peptides for high level production of therapeutic antibodies in CHO cells. A databa...
Main Authors: | Ryan Haryadi, Steven Ho, Yee Jiun Kok, Helen X Pu, Lu Zheng, Natasha A Pereira, Bin Li, Xuezhi Bi, Lin-Tang Goh, Yuansheng Yang, Zhiwei Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4338144?pdf=render |
Similar Items
-
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
by: Peter Bannas, et al.
Published: (2017-11-01) -
Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
by: Peter Bannas, et al.
Published: (2018-11-01) -
Investigation of promiscuity in heavy chain and light chain on anti–alpha enolase antibodies
by: Jing–Ling Hsu, et al.
Published: (2010) -
Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies
by: Starlynn C. Clarke, et al.
Published: (2019-01-01) -
High-resolution description of antibody heavy-chain repertoires in humans.
by: Ramy Arnaout, et al.
Published: (2011-01-01)